Montag & Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.54K | Sell |
60
-149
| -71% | -$18.7K | ﹤0.01% | 769 |
|
|
2025
Q1 | $28.6K | Hold |
209
| – | – | ﹤0.01% | 686 |
|
|
2024
Q4 | $32K | Hold |
209
| – | – | ﹤0.01% | 662 |
|
|
2024
Q3 | $40.5K | Hold |
209
| – | – | ﹤0.01% | 641 |
|
|
2024
Q2 | $48.5K | Hold |
209
| – | – | ﹤0.01% | 599 |
|
|
2024
Q1 | $45.1K | Hold |
209
| – | – | ﹤0.01% | 612 |
|
|
2023
Q4 | $54.1K | Hold |
209
| – | – | ﹤0.01% | 566 |
|
|
2023
Q3 | $53.7K | Sell |
209
-16
| -7% | -$4.11K | ﹤0.01% | 540 |
|
|
2023
Q2 | $64.1K | Hold |
225
| – | – | ﹤0.01% | 517 |
|
|
2023
Q1 | $62.6K | Hold |
225
| – | – | ﹤0.01% | 509 |
|
|
2022
Q4 | $62.3K | Buy |
225
+16
| +8% | +$4.43K | ﹤0.01% | 508 |
|
|
2022
Q3 | $56K | Hold |
209
| – | – | ﹤0.01% | 517 |
|
|
2022
Q2 | $43K | Hold |
209
| – | – | ﹤0.01% | 550 |
|
|
2022
Q1 | $44K | Hold |
209
| – | – | ﹤0.01% | 587 |
|
|
2021
Q4 | $50K | Hold |
209
| – | – | ﹤0.01% | 567 |
|
|
2021
Q3 | $59K | Hold |
209
| – | – | ﹤0.01% | 544 |
|
|
2021
Q2 | $72K | Hold |
209
| – | – | ﹤0.01% | 505 |
|
|
2021
Q1 | $58K | Hold |
209
| – | – | ﹤0.01% | 537 |
|
|
2020
Q4 | $51K | Buy |
+209
| New | +$51K | ﹤0.01% | 535 |
|
|
2015
Q3 | – | Sell |
-549
| Closed | -$222K | – | 236 |
|
|
2015
Q2 | $222K | Hold |
549
| – | – | 0.03% | 235 |
|
|
2015
Q1 | $232K | Buy |
+549
| New | +$232K | 0.03% | 235 |
|